Internal Medicine, Rheumatology · Cedar Rapids, IA
NPI
1215979539
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
202 10th St SE
Cedar Rapids, IA, 52403
Phone (319) 398-1546
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
206,920 services
Medicare patients, 2024
525
Average age 74
Drug cost, 2024
$1.6M
2,498 prescriptions
Company payments, 2024
$99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vijay Aluri was code J3262 (injection, tocilizumab, 1 mg), 102,465 times for 42 patients. In total Vijay Aluri billed 206,920 services in 100 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 102,465 | 42 | $4.70 | $481K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 26,100 | 43 | $9.07 | $237K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 20,370 | 21 | $8.56 | $174K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 13,900 | 26 | $33.79 | $470K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 8,520 | 40 | $24.86 | $212K |
| J0897 Injection, denosumab, 1 mg | Office | 8,400 | 84 | $20.49 | $172K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,161 | 46 | $0.10 | $505 |
| J9312 Injection, rituximab, 10 mg | Office | 4,460 | 20 | $61.26 | $273K |
| 85025 Blood Count | Office | 1,111 | 388 | $7.61 | $8,455 |
| 85652 Clinical Chemistry | Office | 1,095 | 394 | $2.65 | $2,902 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,093 | 27 | $0.23 | $251 |
| 86140 Clinical Chemistry | Office | 1,086 | 396 | $5.08 | $5,512 |
| 82565 Clinical Chemistry | Office | 981 | 310 | $5.02 | $4,925 |
| 84460 Clinical Chemistry | Office | 954 | 292 | $5.19 | $4,951 |
| 84450 Clinical Chemistry | Office | 953 | 292 | $5.08 | $4,841 |
By year: 2022 $1.6M for 125,035 services; 2023 $2.2M for 173,906 services; 2024 $2.4M for 206,920 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,111 | 388 | $7.61 | $8,455 |
| 85652 Clinical Chemistry | 1,095 | 394 | $2.65 | $2,902 |
| 86140 Clinical Chemistry | 1,086 | 396 | $5.08 | $5,512 |
| 82565 Clinical Chemistry | 981 | 310 | $5.02 | $4,925 |
| 84460 Clinical Chemistry | 954 | 292 | $5.19 | $4,951 |
| 84450 Clinical Chemistry | 953 | 292 | $5.08 | $4,841 |
| 36415 Venipuncture Blood Collection | 568 | 354 | $8.65 | $4,913 |
| 82040 Clinical Chemistry | 319 | 202 | $4.85 | $1,547 |
| 86160 Immunoassay | 234 | 99 | $11.66 | $2,728 |
| 80053 Clinical Chemistry | 162 | 127 | $10.35 | $1,677 |
Medicare prescription drug claims, 2024
In 2024, the drug Vijay Aluri prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 676 prescriptions and refills. In total Vijay Aluri wrote 2,498 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 676 | 1,491 | 156 | $24K |
| Methotrexate Methotrexate Sodium | 475 | 1,032 | 117 | $12K |
| Alendronate Sodium Generic | 244 | 425 | 51 | $869 |
| Prednisone Generic | 181 | 247 | 84 | $640 |
| Leflunomide Generic | 139 | 265 | 28 | $6,976 |
| Allopurinol Generic | 130 | 266 | 34 | $526 |
| Humira(Cf) Pen Adalimumab | 127 | 138 | 12 | $927K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 89 | 145 | 18 | $1,531 |
| Sulfasalazine Generic | 53 | 97 | Under 11 | $1,919 |
| Colchicine Generic | 49 | 78 | 17 | $1,522 |
| Sulfasalazine Dr Sulfasalazine | 40 | 88 | Under 11 | $2,075 |
| Leucovorin Calcium Generic | 31 | 61 | Under 11 | $1,223 |
| Folic Acid Generic | 30 | 69 | Under 11 | $328 |
| Actemra Actpen Tocilizumab | 23 | 23 | Under 11 | $113K |
| Losartan Potassium Generic | 23 | 55 | Under 11 | $291 |
Brand drugs: 415 claims; generic drugs: 2,058 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Vijay Aluri $99 ($99 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $99.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.